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Abstract
Reverse transcriptase (RT) of human immunodeficiency virus (HIV)-1 plays a key role in initiating viral replication and is an
important target for developing anti-HIV drugs. Our previous study showed that two mutations (Y271A and I274A) in the
turn RT (Gln269-Arg277) abrogated viral replication, but the replication capacity and RT activity was discordant. In this study,
we further investigated why alanine substitutions at these two sites would affect viral replication. We found that both RT
activity and RT protein were almost undetectable in viral particles of these two mutants, although the Pr160gag-pol mutants
were properly expressed, transported and incorporated. Using protease inhibition assay, we demonstrated a correlation
between the degradation of the RT mutants and the activity of viral protease. Our native gel analysis indicated that the
mutations at 271 and 274 amino acids might cause conformational changes, leading to the formation of higher order
oligomers instead of dimers, resulting in increased protein instability and susceptibility to viral protease. Thus, residues 271
and 274 are critical to RT stability and resistance to viral protease. The conservation of the two amino acid residues among
different strains of HIV-1 lent further support to this conclusion. The knowledge gained here may prove useful in drug
design.
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Introduction
Reverse transcriptase (RT) of human immunodeficiency virus
(HIV)-1, encoded by pol gene, is a multifunctional enzyme that
possesses RNA- and DNA-dependent polymerase activities as well
as RNase H activity [1]. RT is indispensable for HIV-1 and it
converts the single-stranded viral RNA into double-stranded DNA
upon viral entry into host cells. Due to its important role in viral
life cycle, RT is one attractive target for antiviral drug design [2].
The biologically active form of HIV-1 RT is a heterodimer
consisting of two subunits, p66 (66 kDa) and p51 (51 kDa). The
p51 subunit is derived from p66 by proteolytic cleavage of its C-
terminal domain [3]. The polymerase domain of p66 and p51,
resembling a right hand configuration, consists of four subdo-
mains, which are known as fingers, palm, thumb and connection.
The fingers, palm and thumb subdomains of p66 form a nucleic
acid binding cleft and the connection subdomains of the two
subunits form the floor of the nucleic acid binding site [4–7].
The thumb subdomain has four a helices. Two antiparallel a-
helices of them, a-H (Asn255 to Ser268) and a-I (Gln278 to Thr286),
are important for holding the primer/template in position during
the translocation in polymerization. The primary sequence (Val254
to Ala288) in the vicinity of these two a helices has been found to
share homology with several other nucleic acid polymerases and
has been termed the ‘‘helix clamp’’ [5,8]. Extensive studies have
been carried out to shed light on the relationship between the
‘‘helix clamp’’ and function of RT. The effects of alanine-scanning
mutations in a-H and a-I on polymerase activity, primer/template
(P/T) binding, fidelity and enzyme kinetics have been determined.
While mutations in a-I do not affect P/T binding or fidelity
significantly, several a-H mutants exhibit lower binding affinity,
processivity and frameshift fidelity [9–12]. Previous studies have
demonstrated that mutations in these two helices can have
significant effect on RNase H activity, minus-strand DNA transfer
activity and removal of polypurine track primer [13,14].
Although alanine substitutions at sites 269, 270, 271 and 277
have been investigated in two studies [9,10], detailed studies on the
functional structure of the ‘‘turn’’ (Gln269-Arg277) between a-H
and a-I were limited. In our previous study on hepatitis B virus
RT, conserved residues located at the ‘‘turn’’ of helix clamp motif
were found important for pregenomic RNA encapsidation during
the assembly of nucleocapsids [15,16]. Since this homologous helix
clamp motif is also present in HIV-1 RT, we hypothesized that
residues in the turn may play important roles in viral life cycle.
Our recent study showed that alanine substitutions at 271 and 274
of HIV-1 RT drastically affected viral replication, but discordance
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between viral replication and RT activity was observed [17]. In
this study, we confirmed our previous observations and further
investigated why the two mutations abrogated viral replication.
Our study demonstrated that these two mutations lead to rapid
degradation of RT in viral particles, indicating that the residues of
271 and 274 are critical for maintaining the stability of HIV RT.
Methods
Plasmid constructs and cell lines
The parental HIV-1 proviral plasmids, pLAI.2, pNL4-3-DE-
EGFP and pHEF-VSV-G, were obtained through the NIH AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH [18–20]. The pNL4-3-DE-EGFP based mutants
(Y271A, G273A, I274A, K275A, V276A, R277A) and pLAI2
based mutants (Y271A and I274A) were constructed by site-
directed mutagenesis using QuikChange II XL Site-Directed
Mutagenesis Kit (Stratagene, USA) according to manufacturer’s
instruction. The open reading frame of RT p66 subunit was
amplified from wild type or mutant pNL4-3-DE-EGFP using a
pair of primers and cloned into pET-28b vector (Novagen,
Shanghai) to obtain expression plasmid pET-p66 with the 66His
tag at 39 terminus. The paired primers used for site-directed
mutagenesis and construction of plasmids are listed in Table 1.
Cell lines 293FT, HeLa and U373-MAGI-CXCR4CEM [21] were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum and antibiotics
(Invitrogen, USA). MT2 cells [22,23] were maintained in RPMI
1640 supplemented with 10% fetal bovine serum and antibiotics.
Preparation of pseudoviruses and live viruses
To prepare pseudoviruses and live viruses, 293FT cells were co-
transfected with 7.5 mg wild-type or mutant pNL4-3-DE-EGFP,
and 2.5 mg pHEF-VSV-G, or 10 mg wild-type or mutant pLAI.2
using Lipofectamine 2000 (Invitrogen, USA) according to the
manufacturer’s instructions. Supernatants were collected 48 h
after transfection and stored at 280uC after spinning down and
filtering to remove cell debris. The cells were rinsed with ice-cold
phosphate-buffered saline (PBS), scraped from each plate and
lyzed in cell lysis buffer (Boehringer, Germany) and 16 protease
inhibitor cocktail (Roche, USA) on ice for 30 min. Cell lysates
were stored at 220uC after centrifugation at 13,0006g at 4uC for
15 min to remove cell debris.
One cycle infection assay
One cycle infection assay was carried out using normalized
pseudoviruses as described previously [20]. Briefly, Jurkat cells
(0.56106) were infected with viral supernatants containing 250 ng
p24, which was measured by Vironostika HIV-1 antigen
MicroELISA kit (Biomerieux bv Boxtel, Netherlands). The virus
and cells mixture was spun at 1,800 g at 30uC for 2 h. After the 2-
h spin infection, Jurkat cells were washed with 2 ml culture
medium twice, then cultured in 24-well plates at 37uC for 48 h.
The cells were collected and washed twice with PBS. After the cells
were fixed with 1% paraformaldehyde in PBS for 30 min on ice,
the infected cells, as determined by the expression of GFP, were
measured using a FACSCalibur instrument (Becton Dickinson,
USA) and analyzed with Cell Quest software (Becton Dickinson,
USA) as described previously [20].
Infection assays with live viruses
Infection with live viruses was conducted in U373-MAGI-
CXCR4CEM and MT-2 cells. U373-MAGI-CXCR4CEM cells
were infected with normalized wild type or mutant live viruses in
24-well plate as described previously [21]. Briefly, triplicate wells
(66104 cells/well) were infected with live viruses (60 pg p24/well)
which were diluted in DMEM containing 20 mg/ml of DEAE-
dextran (Amersham Biosciences). After cultured at 37uC in 5%
CO2 incubator for 48 h, the cells were fixed in 1% formaldehyde-
0.2% glutaraldehyde in PBS for 5 min. After washing twice with
PBS, the cells were stained with 400 mg/ml of X-Gal (5-bromo- 4-
chloro-3-indolyl-b-D- galactopyranoside), 4 mM MgCl2, 4 mM
potassium ferrocyanide, and 4 mM potassium ferricyanide in PBS
for 2 h at 37uC. The plate was washed twice with PBS and blue
foci were observed under microscope. Infection with live viruses
was also carried out in MT-2 cells as described previously [22,23].
In brief, MT-2 cells (16104 cells/well) in 96-well plate were
infected with live viruses (20 pg p24/well). After cultured for 6
days, the virus-specific cytopathic effect (CPE) was observed under
microscope.
RT activity assay
The RT activity in pseudoviruses was measured by a RT assay
using colorimetric kit (Roche, USA). Briefly, viral supernatants
containing 2 mg p24 were centrifuged at 4uC for 2 h at 40,0006g
and the viral pellets were resuspended in 50 ml lysis buffer. Lyzed
viral pellets were 10 fold serially diluted and the subsequent
procedures were carried out according to the manufacturer’s
instructions. RT activities of mutants were calculated and
compared to that of wild type pseudovirus.
Immunofluorescence microscopy
Expression and subcellular localization of precursor Gal-Pol
polyprotein were detected by immunofluorescence microscopy as
described previously with some modifications [24]. Briefly, HeLa
cells cultured on coverslip in 24-well culture plate were transfected
with 600 ng pNL4-3-DE-EGFP and 200 ng pHEF-VSV-G. Two
days post-transfection, the cells were fixed with 500 ml 4%
paraformaldehyde (PFA) at room temperature for 15 min. After
Table 1. Primers for site-directed mutagenesis and RT p66
cloning.
Name Sequences
Primers for site-directed mutagenesis
Y271A_F 59-GAATTGGGCAAGTCAGATTGCAGCAGGGATTAAAGTAAGGC-39
Y271A_R 59-GCCTTACTTTAATCCCTGCTGCAATCTGACTTGCCCAATTC-39
G273A_F 59-GGGCAAGTCAGATTTATGCAGCAATTAAAGTAAGGCAATTATG-39
G273A_R 59-CATAATTGCCTTACTTTAATTGCTGCATAAATCTGACTTGCCC-39
I274A_F 59-GGGCAAGTCAGATTTATGCAGGGGCAAAAGTAAGGCAATTATG-39
I274A_R 59-CATAATTGCCTTACTTTTGCCCCTGCATAAATCTGACTTGCCC-39
K275A_F 59-GTCAGATTTATGCAGGGATTGCAGTAAGGCAATTATGTAAAC-39
K275A_R 59-GTTTACATAATTGCCTTACTGCAATCCCTGCATAAATCTG AC-39
V276A_F 59-GTCAGATTTATGCAGGGATTAAAGCAAGGCAATTATGTAAAC-39
V276A_R 59-GTTTACATAATTGCCTTGCT TTAATCCCTGCATAAATCTGAC-39
R277A_F 59-CAGGGATTAAAGTAGCGCAATTATGTAAACTTCTTAGGGG-39
R277A_R 59-CCCCTAAGAAGTTTACATAATTGCGCTACTTTAATCCCTG-39
Primers for p66 cloning
NcoI 59-TAACCCCCATGGGCCCCATT AGTCCTATTGAGACTG-39
XhoI 59-TGAGCAGTCTCGAGTAGTACTTTCCTG ATTC-39
Mutated residues and the enzyme cleavage sequence are underlined.
doi:10.1371/journal.pone.0006108.t001
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washing 3 times with PBS, 500 ml of 50 mM ammonium chloride
was incubated with the cells for 10 min to neutralize residual PFA.
The cells were washed 3 times with PBS and treated with 0.05%
Triton X-100 for 3 min. After washing 3 times with PBS, 500 ml
10% normal rabbit serum (NRS) in PBS was added to block the
slip overnight at 4uC. Primary antibody (mouse monoclonal anti-
integrase, 1:100, Santa Cruz) and secondary antibody (Texas Red
dye-conjugated Rabbit anti-mouse IgG, 1:100, Jackson Immu-
noResearch) were incubated with samples in dark at room
temperature. Following each incubation, samples were subjected
to 3 washes with 1% NRS in PBS. With 3 additional PBS washes,
the coverslip was mounted using fluorescence mounting medium
(Dako) and observed under LSM510 Meta confocal microscope
(Carl Zeiss).
Western blotting
Gal-Pol polyprotein and its products were tested by Western
blotting as described previously with some modifications [25].
Briefly, viral proteins were separated by 10% SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE) and electro-blotted onto
Hybond-P PVDF membrane (GE Healthcare, Bio-sciences).
After blocking with 5% skim milk for 1 h at room temperature,
the membrane was incubated with primary antibodies (Rabbit
polyclonal anti-RT, 1:3000; mouse monoclonal anti-RT, anti-
intergrase, anti-protease or anti-capsid, 1:500) for 1 h. Mem-
brane was washed three times with PBS containing 0.1% Tween
20 (PBS-T) and then incubated with horseradish peroxidase
(HRP)-conjugated secondary antibody (goat anti-rabbit IgG or
goat anti-mouse IgG, 1:4000) for 1 h. After the blots were
rewashed three times in 0.1% PBST, signals were visualized
using ECL Western blotting substrate reagents (Amersham
Biosciences, USA) and KODAK BioMax Scientific Imaging
Film (Eastman Kodak).
Expression and analysis of RT p66
Wild type and mutant pET-p66 expression vectors were
respectively transformed into E. coli BL21(DE3) and the expression
was induced with 0.3 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) when E. coli grew up to an OD600 of 0.7,1.0. E. coli
expressing p66 was spun down and re-suspended in the binding
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole).
After the bacteria were disrupted by ultrasonication and
centrifuged at 15 000 g for 30 min at 4uC, the wild type and
mutant p66 in supernatants were purified using Ni-NTA magnetic
agarose beads (Qiagen, Germany). The purified p66 proteins were
subjected to NativePage Novex Bis-Tris gel analysis and Western
blotting according to the protocol recommended by Invitrogen,
USA.
Sequence alignments and structural analysis
RT sequences of 1083 HIV-1 strains obtained from the HIV
complete sequence database (http://www.hiv.lanl.gov/content/
sequence/NEWALIGN/align.html) were aligned and compared.
Based on the X-ray crystal structures of HIV-1 RT (1RTH) from
the Research Collaboratory for Structural Bioinformatics Protein
Data Bank (RCSB PDB), structural models of wild type and
mutant RTs were analyzed using Swiss-PdbViewer software
(http://spdbv.vital-it.ch/).
Statistical analysis
Statistical analysis of RT activities was performed by Student’s t
test using Stata statistical software. Results were considered
significant at P#0.05.
Results
Y271A and I274A mutations abrogated viral replication
The effect of six RT mutations at the helix clamp turn in HIV-1
RT on viral replication was tested with pseudoviruses. When
Jurkat cells were infected with the wild type and mutant
pseudoviruses (250 ng p24 virus/56105 cells), viral replication
was almost completely inhibited in the mutants Y271A and I274A,
while replication of other mutants did not show significant
difference as compared to that of the wild type (Fig. 1A). A
similar result was also obtained when the cells were infected with
lower amount (150 ng p24) of pseudoviruses (data not shown). To
confirm the above results, replication of wild type, Y271A and
I274A live viruses was further monitored in U373-MAGI-
CXCR4CEM and MT2 cells. Mutants Y271A and I274A were
undetectable in U373-MAGI-CXCR4CEM cells (Fig. 1B) and no
virus-specific CPE was found in MT-2 cells (Fig. 1C). Since reverse
transcription is the first step for HIV replication after viral entry
into host cells, our results suggested that the two mutations might
have affected the RT activity.
RT activity and RT proteins were undetectable in
pseudoviral particles of mutants Y271A and I274A
We thus interrogated the pseudovirus mutants for RT activity.
The RT activity recovered from mutants Y271A and I274A were
almost unnoticeable, as compared with that of wild type (Fig. 2A).
This result was further confirmed using wild type, Y271A and
I274A live viruses (data not shown). Next, we asked if the viral
particles contain dysfunctional RT or the RT was not incorpo-
rated into the viral particles. By Western blotting, RT protein was
basically undetectable in viral particles of these two mutants
(Fig. 2B). The results suggested that the mutations could affect the
incorporation of RT into the viral particles, leading to a defect in
reverse transcription which initiates viral replication.
Mutations Y271A and I274A did not affect Pr160gag-pol
expression and transportation
We next investigated whether the loss of RT in viral particles of
the mutants was attributed to altered expression and transporta-
tion of the precursor protein, polyprotein Pr160gag-pol, during virus
assembly. Pr160gag-pol in lysates of cells transfected with the wild
type and mutants was detected by Western blotting. As shown in
Fig. 3A, similar levels of Pr160gag-pol, Gag protein (Pr55Gag) and
capsid protein p24 (CA p24) were found in cells transfected with
the wild type or mutant constructs, indicating that the expression
and stability of RT precursor protein were not affected by the
mutations. Immunofluorescence staining further demonstrated a
normal subcellular localization of mutant Gag-Pol polyproteins as
compared to that of the wild type, suggesting that the
transportation of Gag-Pol was unlikely to be affected by alanine
substitutions (Fig. 3B).
The Gag-Pol polyprotein was incorporated into mutant
virions of Y271A and I274A, but the RT was degraded by
viral protease
To investigate whether the precursor Gag-Pol polyprotein was
indeed incorporated into pseudoviral particles of mutants Y271A
and I274A, products of the Gag-Pol polyprotein, integrase (IN),
protease (PR) and p24, in wild type and mutant pseudoviral
particles were examined by Western blotting. The results showed
that, except for RT (Fig. 2B), all products of the Gag-Pol
polyprotein, IN p32, PR p11 and CA p24, were detected in the
mutants Y271A and I274A at a level similar to that of the wild
271/274 and RT Stability
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type pseudoviral particles (Fig. 4A). Thus, Pr160gag-pol was indeed
incorporated into the virions and processed properly. To study if
the RTs in the viral particles of Y271A and I274A mutants were
degraded by proteolysis that made them undetectable, pseudo-
viruses of wild type and mutants were generated in the presence or
absence of indinavir, a highly specific inhibitor of HIV-1 protease.
Indinavir treatment was effective, because the treatment resulted
in a dose-dependent inhibition of Pr55Gag processing into p24 for
wild type and mutant viruses (Fig. 4B). As shown in Fig. 4C, in the
absence of indinavir, both RT p66 and p51 were readily detected
in the wild type pseudovirus, but not in the mutant viruses. In the
presence of indinavir, however, both RT p66 and p55 were
markedly reduced in the wild type virus but became detectable in
mutant Y271A viral particles, while RT p66 was also detectable in
mutant I274A virus. We also detected the RT subunits in the viral
supernatants collected at earlier time points (12, 24 and 36 hours
post-transfection), but the mutant RTs were still undetectable (data
not shown). These results suggested that the Y271A and I274A
RTs were degraded after incorporation of Gag-Pol polyprotein
into the virions, which might be attributed to the activity of viral
protease.
Y271A and I274A substitutions affected dimer-formation
of RT
Since RT dimer is the stable form which remains resistant to the
proteolysis, we tested whether treatment of dimerization enhancer
could reduce the mutant RT proteolysis. Wild type and mutant
pseudoviruses were generated in the presence or absence of
Efavirenz (EFV), the most potent dimerization enhancer [26]. The
results showed that the RT mutants were still undetectable in the
presence of EFV (Fig. 5A). The conformation of the wild type and
mutant RT p66 was further analyzed by native gel electrophoresis
followed by Western blotting (Fig. 5B). Under native conditions,
wild type p66 subunit formed homodimer. However, the
formation of homodimer in mutant Y271A was markedly reduced
and a higher order oligomer appeared, which might be tetramer
Figure 1. Infection with wild type and mutant pseudoviruses and live viruses. (A) Infection of Jurkat cells with wild type and six mutants of
pseudovirus was detected by flow cytometry. The uninfected Jurkat cells (uninfected) were included as negative control. The infection was
determined by the positive rate of infected cells expressing GFP, which was carried by the virus, at 48 h post-infection. Values presented in this figure
are representative results of 3 independent experiments. (B) Infection of U373-MAGI-CXCR4CEM cells with wild type as well as Y271A and I274A
mutants of live HIV-1 virus. The infection was determined by the number of blue-staining foci (infectious units) in the cells at 48 h post-infection
(original magnification of microscope: 2006). (C) Infection of MT2 cells with wild type as well as Y271A and I274A mutants of live HIV-1. The infection
was assessed by observation of virus specific cytopathic effect (CPE) in the cells on day 6 post-infection. Cells were observed under fluorescent
microscope (original magnification: 1006).
doi:10.1371/journal.pone.0006108.g001
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according to its molecular weight, while mutant I274A existed as
at least two higher order oligomers, which were likely tetramer and
octamer based on their molecular weights. However, the exact
nature of the oligomers formed by mutant p66 subunits remained
to be clarified. Furthermore, the treatment with b-mercaptoeth-
anol could partially disrupt the higher order oligomers and
improve dimer formation. This result implicated that dimer
formation might be necessary for the stability of RT and its
resistance to proteolysis after incorporation of Gag-Pol polyprotein
into the viral particles.
Amino acids at 271 and 274 are relatively conserved and
big side chains may be important in maintaining RT
stability and resistance to proteolysis
By comparing 1083 complete sequences of HIV-1, it was found
that the amino acids at 271 and 274 were relatively conserved. As
shown in Table 2, tyrosine (Y) is the predominant naturally
existent amino acid at 271 residue (99.19%), while phenylalanine
(F), histidine (H) and cysteine (C) occur rarely (,1%). Similarly,
isoleucine (I) is the predominant naturally existent amino acid at
274, which accounts for 98.43%, while in less than 2% of all cases,
valine (V) and leucine (L) are found at this site. This finding
suggested that these amino acids might probably play important
role in maintaining the active conformation of RT. Consistently,
structural analysis suggested that amino acids at these two sites are
buried in the thumb region of RT (Fig. 6A). It was further revealed
that all wild type RTs have relatively big side chains, but they are
absent from the mutants 271A and 274A (Fig. 6B & 6C). Thus, the
loss of the side chains in the RT mutants plausibly leads to
conformational change of RT, leading to aberrance in dimer
formation and susceptibility to proteolysis by HIV-1 protease.
Discussion
HIV RT plays a key role in viral replication and is an important
target for development of anti-HIV drugs. However, the turn
between helices H and I of HIV-1 RT thumb region (amino acid
residues 269 to 277) has not been well characterized yet. To
understand the structure-function relationship of this turn in
details, we investigated whether alanine substitutions in this region
would affect RT activity. Except for residues 269 and 270, which
have been reported to have no significant influence on RT activity
[9,10], and for residue 272, which is originally an alanine, six
mutant pseudoviruses (residues 271 and 273 to 277) were
constructed and viral replication was compared with that of the
Figure 2. Detection of RT activity and RT protein in pseudo-
viruses. (A) RT activity in wild type (WT) and mutant pseudoviruses was
tested by reverse transcriptase assay using a colorimetric kit. The viral
particles in supernatant were concentrated and normalized (6 ng p24).
The results are expressed as mean % of 3 independent experiments as
compared to RT activity in wild type virus. (B) RT protein in lysed viral
particles was detected by Western blotting using rabbit polyclonal anti-
RT antibody. The assays showed that both RT activity and protein in
mutant pseudoviruses Y271A and I274A were almost undetectable.
doi:10.1371/journal.pone.0006108.g002
Figure 3. Expression and subcellular distribution of Gag-Pol
polyprotein. (A) The expression of Gag-Pol polyprotein (Pr160Gag-pol),
Gag protein (Pr55Gag) and capsid protein p24 (CA p24) in lysed cells
transfected with pseudoviral vectors expressing wild type (WT) or six
indicated mutants of RT was detected by Western blotting using mouse
monoclonal anti-CA primary antibody and goat anti-mouse IgG HRP-
conjugated secondary antibody. (B) The subcellular distribution of
Pr160Gag-pol in HeLa cells transfected with pseudoviral vectors for wild
type (WT) RT or Y271A and I274A mutants were further detected by
immunofluorescence staining using mouse monoclonal anti-integrase
primary antibody and Texas Red dye-conjugated rabbit anti-mouse IgG
secondary antibody. The positive cells were visualized under fluores-
cence microscope (original magnification: 4006, bar = 10 mm).
doi:10.1371/journal.pone.0006108.g003
271/274 and RT Stability
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wild type virus. The replication of two mutants, Y271A and
I271A, were found to be almost completely abolished (Fig. 1A).
This result was further confirmed in live virus system (Fig. 1B &
1C). Since it has been reported that bacterially expressed Y271A
mutant has only 1% activity of wild type enzyme [9], we asked
whether the mutants would similarly affect RT activity in the viral
particles. The results showed that the RT activity was basically
undetectable in viral particles of these two mutants (Fig. 2A). It was
also found that the loss of RT activity in the viral particles might
be attributed to the absence of RT in the viral particles rather than
the incorporation of dysfunctional RT into the virions (Fig. 2B).
After viral entry into the cells, the first step of HIV-1 replication is
reverse transcription. Our results thus suggested that replication of
mutant viruses was abrogated, because the mutant RT did not
exist in the virion.
Since HIV-1 RT is incorporated into the virion in the form of
Pr160gag-pol, which is transported to cell membrane where the
virus is packaged, through interaction with Pr55gag [27–30], we
thus investigated whether the mutations would affect Pr160gag-pol
expression and transportation. Our results showed that Pr160gag-
pol was properly expressed and transported in cells transfected with
mutant constructs, Y271A and I271A (Fig. 3), indicating that these
mutations did not affect either the production of the precursor or
the interaction between Pr160gag-pol and Pr55gag. It was further
found that the Pr160gag-pol was indeed incorporated into the
virions of these two mutants, because except for RT, all other
products of Pr160gag-pol including p24, protease and integrase
[31,32], could be detected in the viral particles of mutants Y271A
and I271A (Fig. 4A). Although it has been reported that the
domain between residues 183 and 305 of RT is likely responsible
for RT incorporation [33], our study ruled out the involvement of
Figure 4. Detection of Gag-Pol polyprotein products in
pseudoviral particles and the protease inhibition assay. (A)
Cleavage products of Gag-Pol polyprotein, integrase (IN p32), protease
(PR p11) and capsid protein p24 (CA p24) in wild type (WT) and mutant
pseudoviruses were detected by Western blotting using mouse
monoclonal anti-IN, anti-PR and anti-CA antibodies, respectively. (B)
Pr160Gag-pol, Pr55Gag and CA p24 were detected in wild type (WT) as
well as Y271A and I274A mutant pseudoviruses produced in the
absence (0) or presence of 0.2 and 2 mM protease inhibitor (indinavir) by
Western blotting using mouse monoclonal anti-CA. (C) Pr160Gag-pol and
its subunits RT p66 and p51 were detected in wild type (WT) as well as
Y271A and I274A mutant pseudoviruses produced in the absence (0) or
presence of 0.2 and 2 mM protease inhibitor (indinavir) by Western
blotting using mouse monoclonal anti-RT antibody.
doi:10.1371/journal.pone.0006108.g004
Figure 5. Detection of dimmer-formation of mutant RT. (A) RT
was detected in wild type and mutant pseudoviruses generated in the
presence and absence of EFV, the most potent dimerization enhancer,
by Western blotting using mouse monoclonal anti-RT and anti-CA p24
antibodies, respectively. (B) Purified wild type and mutant RT subunit
p66 were analyzed by native gel electrophoresis followed by Western
blotting using mouse monoclonal anti-RT antibody in the presence or
absence of b-mercaptoethanol (b-ME). Compared with wild type p66,
which basically existed as homodimer, p66 subunit of the 271A and
274A mutants formed higher order oligomers, suggestive of confor-
mational change.
doi:10.1371/journal.pone.0006108.g005
271/274 and RT Stability
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the turn (Gln269-Arg277). Another report has suggested that two
mutations in RT, L234D and W239A, led to premature cleavage
of the Gag-Pol precursor and reduced levels of viral enzymes in the
virions [34]. Our results also excluded that the mutations of
Y271A and I271A affected the cleavage of the Gag-Pol precursor.
By a viral protease inhibition assay using indinavir, we finally
demonstrated that the RT mutants were degraded after incorpo-
ration of the precursor polyprotein into the virions and the
degradation was associated with the activity of viral protease
(Fig. 4C). Our results indicated that the mutations in residues 271
and 274 would reduce the stability of RT inside the viral particles,
rendering it susceptible to viral protease.
Post-incorporation degradation of RT has been reported
previously. Wapling et al. [35] have reported that mutations of
W401L and W401A in RT can inhibit RT dimerization, resulting
Figure 6. Structural models of naturally existent and artificially introduced substitutions of residues 271 and 274. We take p51
subunit as an example. (A) Locations of residues 271 and 274 in HIV-1 RT subunits p66 (grey) and p51 (green) (PDB coordinate 1RTH). The left panel
shows a better view of residue 271 (blue); while the right panel reveals a better view of residue 274 (pink). (B) Structural models of naturally existent
271Y, 271F, 271H and 271C residues as well as the lethal 271A mutation of p51 subunit. The same area was highlighted above in the left panel of
Fig. 6A. A big side chain (blue) is found in naturally occurring residues but not in 271A. (C) Structural models of naturally existing 274I, 274V and 274L
residues as well as the lethal 274A mutation of p51 subunit. The same region was highlighted above in the right panel of Fig. 6A. A big side chain
(pink) is found in naturally occurring residues I, V and L, but not in 274A.
doi:10.1371/journal.pone.0006108.g006
Table 2. Frequencies of naturally existent amino acid
residues at 271 and 274 of HIV-1 RT.
Location in HIV-1 RT Amino acids Frequency
Y 99.19%
271 F 0.55%
H 0.18%
C 0.09%
I 98.43%
274 V 1.48%
L 0.09%
doi:10.1371/journal.pone.0006108.t002
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in reduced steady-state level of the RT subunits p66 and p51 in
viral lysate, while Gag-Pol was not affected. They also showed that
HIV-1 protease contributed to the degradation of RT subunits in
the virions. A similar result was also observed when mutations
were introduced into the protease cleavage site between RT p51
and RNase H domain [36]. Another mutation, L289K in p66
subunit, has also been reported to be able to abrogate dimerization
[37]. Another group, when they tried to generate infectious
molecular clones of Simian Immunodeficiency Virus, found that
glutamic acid replacement at position 287 affected the stability of
RT [38]. The biologically active and stable form of HIV-1 RT is a
heterodimer consisting of p66 and p51, while the immediate
precursor of p66/p51 heterodimer is the p66 homodimer.
Proteolytic removal of the RNase H domain in one of the p66
homodimer subunit by HIV-1 protease leads to the formation of
stable heterodimer p66/p51 [39]. RT exists as an equilibrium
mixture of monomers and dimers that include the p66/p51
heterodimer and the p66/p66 and p51/p51 homodimers, among
which the heterodimer is the most stable and the p51/p51
homodimer is the most unstable [40–43]. Plausibly, the degrada-
tion of RT as reported in previous studies may be ascribed to the
inhibition of RT p66 dimerization by the mutations.
The mechanism of RT degradation in the virions observed in
this study, however, may be different. Our results showed that RT
mutants were still undetectable in the viruses generated in the
presence of a potent dimerization enhancer (Fig. 5A). Our native
gel analysis showed that the dimer form of RT mutant 271A was
detected, although it was markedly reduced as compared to the
wild type, while mutant 274A could not form dimer. Instead,
higher order oligomers of RT were detected in both mutants
(Fig. 5B). It has been reported that higher order oligomerization
may occur in HIV-1 RT [41,44,45]. Our results have also
indicated that Y271A and I274A substitutions may change the
conformation of RT, leading to oligomerization. The higher order
oligomers formed in these 2 mutants, perhaps tetramer and
octamer, may be associated with instability of RT mutants and
their susceptibility to viral protease. Furthermore, according to the
locations of residues 271 and 274 (Fig. 6A), it is highly probable
that alanine substitutions at 271 and/or 274 can affect the
conformation of p51 thumb region and subsequently its interac-
tion with RNase H domain of p66, resulting in the exposure of the
7-amino-acid p51-RNas H cleavage sequence in the p66 subunit
[7,46] and consequent proteolytic degradation by HIV-1 protease.
The relative conservation of RT 271 and 274 residues and the loss
of big side chains at these two sites in the mutants as shown in the
structural models (Fig. 6B & 6C) also support their important roles.
We tried to demonstrate this in vitro, by treating wild type and
mutant RTs with recombinant protease, but wild type RT, as well
as mutant RTs, could not be digested in vitro (data not shown).
This result is consistent with that reported by Abram and Praniak
[36]. This could be explained by different proteolytic stability of
RT in vitro and in virions.
Taken together, our study showed that alanine substitutions at
residue 271 or 274 of HIV-1 RT could cause conformational
changes, rendering RT unstable and susceptible to viral protease.
Thus, it is demonstrated that the ‘‘turn’’ (Gln269-Arg277) between
two helices may be important in maintaining protein stability and
formation of bioactive dimer. Mutations in residues 271 and 274
of RT may inactivate the virus, which may enter cells but can not
replicate. These findings may prove useful in anti-HIV drug design
and vaccine development. Considering the emergence of resis-
tance to the current RT inhibitors, this turn, especially amino acid
residues 271 and 274, may be an ideal new target for antiviral
drug design. The agents targeting this region may be able to affect
the stability or dimerization of HIV-1 RT and subsequently inhibit
viral replication. Moreover, the potential drug resistant mutations
in this region, especially at residues 271 and 274, may probably
inactivate the virus, which prevents the appearance of drug-
resistant virus.
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